Where is Leeza located?

Leeza is headquartered in Hyderabad, India.

Who is the current CEO of Leeza?

Mohammed Ibrahim Raza of Leeza. They have also founded 1 company.

How many employees does Leeza have?

As of Apr 30, 2026, the latest employee count at Leeza is 14.

Is Leeza a funded company?

Leeza is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Leeza rank among its competitors?

Leeza ranks 6th amongst 13 active competitors, of which 5 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was MARAbio, which secured $19.1M in Sep, 2024.

Who are the top competitors of Leeza?

Leeza's top competitors include Linus Biotechnology, MARAbio and Lineagen. Among them, MARAbio secured the most recent funding round in September, 2024.

Leeza - 2026 Company Profile, Team & Competitors

Leeza is an unfunded company based in Hyderabad (India), founded in 2023 by Mohammed Ibrahim Raza. It operates as an AI-powered screening assessments for the early detection of autism. Leeza has not raised any funding yet. The company has 13 active competitors, including 5 funded and 1 that has exited. Its top competitors include companies like Linus Biotechnology, MARAbio and Lineagen.

Company Details

AI-powered screening assessments for the early detection of autism. It offers evidence-based tools and guidance to help users navigate various aspects of autism, including diagnosis, treatment, and management. It provides personalized consultation and connections to professional diagnostic centers based on assessment results.

Website: leeza.app
Social
Email ID: *****@leeza.app
Phone Number: +91 **********

Key Metrics

Founded Year

2023

Location

Hyderabad, India

Stage

Unfunded

Ranked

6^th among 13 active competitors

Employee Count

14 as on Apr 30, 2026

Similar Companies

Linus Biotechnology & 12 more

View Leeza's full profile

Leeza has not raised any funding rounds yet.

The founders of Leeza is Mohammed Ibrahim Raza. Mohammed Ibrahim Raza is the CEO of Leeza.

Here are the details of Leeza's key team members:

Mohammed Ibrahim Raza: Founder & CEO of Leeza.

View details of Leeza's Founder profiles and Board Members

Leeza's employee count trend

Leeza has 14 employees as of Apr 26. Here is Leeza's employee count trend over the years:

Uncover Leeza's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Leeza include Linus Biotechnology, MARAbio and Lineagen. Here is the list of Top 10 competitors of Leeza, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Linus Biotechnology 2020, New York City (United States), Series A	Developer of diagnostic tests for central nervous system and gastrointestinal disorders	$47.6M	GreatPoint Ventures, Bow Capital & 3 others	55/100
2nd	MARAbio 2016, Salt Lake City (United States), Series A	Developer of blood test for detecting maternal autoantibody-related autism	$19.1M	MAK Capital, Moai Capital	50/100
3rd	Lineagen 2002, Salt Lake City (United States), Acquired	Sequencing-based diagnostic test and consultative services for autism	$66.9M	Health Quest Capital, Mesa Verde Venture Partners ... & 10 others	46/100
4th	SynapDx 2010, Southborough (United States), Deadpooled	Developer of blood-based diagnostic tests for the early detection of autism	$32.8M	Google Ventures, General Catalyst & 7 others	38/100
5th	FBB Biomed 2020, Coralville (United States), Seed	Developer of in-vitro diagnostic test for COVID-19 and neurological diseases	$401K	-	28/100
6th	Leeza 2023, Hyderabad (India), Unfunded	AI-powered screening assessments for the early detection of autism	-	-	27/100
7th	BioROSA Technologies 2018, Boston (United States), Seed	Developer of blood tests for early detection of Autism Spectrum Disorder	$1.03M	IndieBio, OCA Ventures & 2 others	26/100
8th	SensOmics 2007, Toronto (Canada), Seed	Provider of precision medicine for children's health	-	iSeed Ventures, Asset Management Ventures	26/100
9th	Pediatric Bioscience 2006, Sacramento (United States), Deadpooled	Blood biomarker based diagnostics for Autism Spectrum Disorders	$2.44M	Tech Coast Angels, Arizona Tech Investors	24/100
10th	Analutos 2010, Sunderland (United Kingdom), Unfunded	Mass Spectrometry-based tests for autism spectrum disorders & Dysbiosis	-	-	23/100